FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4297267181> ?p ?o ?g. }

• W4297267181 endingPage "937" @default.
• W4297267181 startingPage "930" @default.
• W4297267181 abstract "Second hip fractures worsen the quality of life and are associated with increased mortality. We clarified the association between the pharmacotherapy and second hip fracture prevention.The relationship between the incidence of second hip fracture and the presence, type and medication possession ratio (MPR) of pharmacotherapy was investigated using medical insurance data from the National Database of Health Insurance Claims and Specific Health Checkups of Japan during April 2012 to March 2019.Data of 776 040 female patients were analyzed. The 2-year rate of second hip fractures was 3.31% (n = 25 684). Bisphosphonates (n = 148 138, 19.1%) were the most commonly used medications after primary hip fracture. Patients receiving selective estrogen receptor modulators (SERMs) had the lowest age, followed by those receiving bisphosphonates, denosumab and parathyroid hormone (PTH). The second hip fracture crude incidence was lowest in patients administered SERMs (n = 859, 2.44%), followed by those administered bisphosphonates (n = 4451, 3.00%), denosumab (n = 484, 3.19%), no medication (n = 19 017, 3.39%) and PTH (n = 873, 5.35%); however, the age-adjusted incidence was the lowest in patients administered denosumab (2.22%), followed by those administered bisphosphonates (2.35%), SERMs (2.39%), no medications (3.39%) and PTH (3.67%). The MPR was highest in patients administered denosumab (60.0%). Among patients without a second hip fracture, the rate of patients with MPR ≥80% was highest among those administered SERMs (40.8%), followed by those administered bisphosphonates (38.0%), denosumab (35.4%) and PTH (12.2%).Differences in patient background characteristics and the rate of patients with MPR ≥80% might underlie the observed differences in the crude incidence of second hip fracture among the medication groups. Geriatr Gerontol Int 2022; 22: 930-937." @default.
• W4297267181 created "2022-09-28" @default.
• W4297267181 creator A5005068184 @default.
• W4297267181 creator A5024937851 @default.
• W4297267181 creator A5032501751 @default.
• W4297267181 creator A5042504091 @default.
• W4297267181 creator A5049867308 @default.
• W4297267181 creator A5061385250 @default.
• W4297267181 creator A5084226691 @default.
• W4297267181 date "2022-09-27" @default.
• W4297267181 modified "2023-10-02" @default.
• W4297267181 title "Association of pharmacotherapy with the second hip fracture incidence in women: A retrospective analysis of the National Database of Health Insurance Claims and Specific Health Checkups of Japan" @default.
• W4297267181 cites W1966813919 @default.
• W4297267181 cites W1990311075 @default.
• W4297267181 cites W2001110947 @default.
• W4297267181 cites W2026344725 @default.
• W4297267181 cites W2048541373 @default.
• W4297267181 cites W2110022366 @default.
• W4297267181 cites W2131208300 @default.
• W4297267181 cites W2141180254 @default.
• W4297267181 cites W2284737234 @default.
• W4297267181 cites W2397337155 @default.
• W4297267181 cites W2518223513 @default.
• W4297267181 cites W2565810605 @default.
• W4297267181 cites W2606836745 @default.
• W4297267181 cites W2608639190 @default.
• W4297267181 cites W2741356572 @default.
• W4297267181 cites W2757319000 @default.
• W4297267181 cites W2922053311 @default.
• W4297267181 cites W2924633197 @default.
• W4297267181 cites W2969837334 @default.
• W4297267181 cites W2974127043 @default.
• W4297267181 cites W2981260944 @default.
• W4297267181 cites W3039038948 @default.
• W4297267181 cites W3040470989 @default.
• W4297267181 cites W3157965032 @default.
• W4297267181 cites W3199709069 @default.
• W4297267181 cites W3201288208 @default.
• W4297267181 doi "https://doi.org/10.1111/ggi.14485" @default.
• W4297267181 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36167466" @default.
• W4297267181 hasPublicationYear "2022" @default.
• W4297267181 type Work @default.
• W4297267181 citedByCount "3" @default.
• W4297267181 countsByYear W42972671812022 @default.
• W4297267181 countsByYear W42972671812023 @default.
• W4297267181 crossrefType "journal-article" @default.
• W4297267181 hasAuthorship W4297267181A5005068184 @default.
• W4297267181 hasAuthorship W4297267181A5024937851 @default.
• W4297267181 hasAuthorship W4297267181A5032501751 @default.
• W4297267181 hasAuthorship W4297267181A5042504091 @default.
• W4297267181 hasAuthorship W4297267181A5049867308 @default.
• W4297267181 hasAuthorship W4297267181A5061385250 @default.
• W4297267181 hasAuthorship W4297267181A5084226691 @default.
• W4297267181 hasConcept C120665830 @default.
• W4297267181 hasConcept C121332964 @default.
• W4297267181 hasConcept C121608353 @default.
• W4297267181 hasConcept C126322002 @default.
• W4297267181 hasConcept C167135981 @default.
• W4297267181 hasConcept C2776286101 @default.
• W4297267181 hasConcept C2776541429 @default.
• W4297267181 hasConcept C2778885795 @default.
• W4297267181 hasConcept C2779889926 @default.
• W4297267181 hasConcept C500440147 @default.
• W4297267181 hasConcept C530470458 @default.
• W4297267181 hasConcept C61511704 @default.
• W4297267181 hasConcept C71924100 @default.
• W4297267181 hasConcept C84606932 @default.
• W4297267181 hasConceptScore W4297267181C120665830 @default.
• W4297267181 hasConceptScore W4297267181C121332964 @default.
• W4297267181 hasConceptScore W4297267181C121608353 @default.
• W4297267181 hasConceptScore W4297267181C126322002 @default.
• W4297267181 hasConceptScore W4297267181C167135981 @default.
• W4297267181 hasConceptScore W4297267181C2776286101 @default.
• W4297267181 hasConceptScore W4297267181C2776541429 @default.
• W4297267181 hasConceptScore W4297267181C2778885795 @default.
• W4297267181 hasConceptScore W4297267181C2779889926 @default.
• W4297267181 hasConceptScore W4297267181C500440147 @default.
• W4297267181 hasConceptScore W4297267181C530470458 @default.
• W4297267181 hasConceptScore W4297267181C61511704 @default.
• W4297267181 hasConceptScore W4297267181C71924100 @default.
• W4297267181 hasConceptScore W4297267181C84606932 @default.
• W4297267181 hasIssue "11" @default.
• W4297267181 hasLocation W42972671811 @default.
• W4297267181 hasLocation W42972671812 @default.
• W4297267181 hasOpenAccess W4297267181 @default.
• W4297267181 hasPrimaryLocation W42972671811 @default.
• W4297267181 hasRelatedWork W139984536 @default.
• W4297267181 hasRelatedWork W1869903362 @default.
• W4297267181 hasRelatedWork W2396479913 @default.
• W4297267181 hasRelatedWork W2769669874 @default.
• W4297267181 hasRelatedWork W2784328911 @default.
• W4297267181 hasRelatedWork W2905624307 @default.
• W4297267181 hasRelatedWork W3023704448 @default.
• W4297267181 hasRelatedWork W4297267181 @default.
• W4297267181 hasRelatedWork W4322617676 @default.
• W4297267181 hasRelatedWork W2186476187 @default.
• W4297267181 hasVolume "22" @default.
• W4297267181 isParatext "false" @default.

• next